Alistair McIntyre and Tom Cowan Explore Latest Section 101 Patent Eligibility Developments in Inventors Digest Article
In their recent Inventors Digest article, Knobbe Martens lawyers Alistair McIntyre and Tom Cowan examine key developments in Section 101 patent eligibility, and offer practical guidance for inventors navigating complex...
Dozens of Knobbe Martens Partners Recognized in 2026 IAM Patent 1000 Guide
IRVINE, Calif., May 28, 2026 – Knobbe Martens, a leading intellectual property law firm, and its partners were once again recognized for excellence across patent law in the 2026 edition...
Federal Circuit Confirms Patent Eligibility of Gene Therapy Patent in Regenexbio Inc. v. Sarepta Therapeutics
Key Takeaway: Genetically engineered cultured host cells containing recombinant nucleic acids useful for gene therapy are patent-eligible for being markedly different from anything occurring in nature. In REGENXBIO Inc. v....